Latest News
Direxion Biotech 3X ETF (LABU) Stock Price Has Risen 12.6% in a Month
Key points: The LABU stock price has risen 12.65% in the past month. The leveraged ETF has outperformed the underlying index.
Aston Martin (AML) Shares Fell 2.17% Despite Positive H1 Report
Key points: The Aston Martin share price edged lower despite an upbeat H1 report. Investors barely reacted since they expected positive results any
ECB Bancorp, ECBK, Up 52% On Demutualisation And Float – More To Come?
Key points: ECB Bancorp stock has jumped after the IPO This is usually defined as a successful IPO But are we considering this the wrong way around?
Boohoo Shares Rallied Despite CMA’s Green Claims Investigation
Key points: The Boohoo share price edged higher despite the CMA’s investigation. The CMA is investigating Boohoo, ASOS and Asda on their green clai
Power Metal, POW, Drifts On First Class Metals, FCM, Float – Will This Improve?
Key points: FCM has just floated in London Power Metal owns a large piece of FCM POW shares haven't moved much, showing the FCM float was about rightly priced
Supply@Me Shares Surged 11% on Progress Update. Is It a Buy?
Key points: The SYME share price surged 11.1% after issuing a progress update. The company is about to close its first inventory monetisation contr
Roku Down 82% Over Year, Another 25% Premarket – Can It Recover?
Key points: Roku stock's down 82% over the past 12 months Another 25% overnight too It's not just past results, the future looks rockier too Roku (N
Final Ethereum Update Set, Before The Merge
Key points: Dev Confirms Goerli Merger Date The Final Update Before The Merge Recap: What Is The Merge? Tim Beiko, lead Ethereum developer this week
Tintra Jumps 37% – Is The Corporate Restructure Working?
Key points: Tintra shares jumped this morning on restructuring news Tintra continues the already announced changes in business lines Out with the old lottery business, i
JetBlue Stock Is Unmoved by the Spirit Airlines Takeover. Here’s Why.
Key points: Jetblue airways just announced a deal to acquire Spirit Airlines. However, its share barely moved due to the looming antitrust concerns
Novavax Stock Price Has Fallen 60.5% in 2022. Can It Rebound?
Key points: Novavax stock price has fallen 60.5% in 2022. Can it stage a rebound? Multiple significant delays precipitated the stock’s decline. To rebound, the
Southwest Airlines (LUV) Stock Slides Despite Earnings, Revenue Beat
Key points: Southwest Airlines reports earnings before the bell The carrier beat earning and revenue forecasts However, shares are down more than 4% premarket
Athersys (ATHX) Stock Is Down 78% YTD. Here’s Why You Should Avoid It
Key points: Athersys stock is down 78% in 2022 and is headed towards liquidation. The firm is set to hold its AGM today, with many hoping for a way
Crypto Jumps Post Fed With Wider “Risk On” Move
Key points: Crypto Markets Broadly Higher Post-Fed Decision Markets Rally With Wider “Risk On” Move Powell Signals Possible Slowing Of Rate Hike Pace
NASDAQ Does It Again, McEwen Mining Is Up 1000%, Not Down 90% – Why?
Key points: NASDAQ had McEwen Mining as being down 90% Actually, McEwen was up 1000% All purely nominal price movements of course, a data error NAS
Amigo Loans (AMGO) Shares Rose 9.12% Despite No News. Here’s Why.
Key points: Amigo Loans’ share price rose 9.12% despite a lack of announcements. The lender’s last significant release was its FY results earlier t
NASDAQ Has GreenPro, GRNQ, Down 90%, It’s Actually Up 1,000% – Why?
Key points: Greenpro Capital is listed as being down 90% today GRNQ is actually up 1000% or so today NASDAQ has made a boo boo Greenpro Capital Co
Ceres Power Shares Rallied 7.78% on Upbeat H1 Update. What’s Next?
Key points: The Ceres Power share price rallied 7.78% after releasing its H1 update. The company had lower revenues but had a promising H2 outlook.
Barclays Down 2.5% On Results – Why Isn’t It Benefitting From Higher Rates?
Key points: Barclays shares fall 2.5% on half year results They're not bad, just not as good as some thought Except, of course, for that capital markets boo boo
Sareum Shares Surged 14.9% on a Clinical Trial Application. Is It a Buy?
Key points: Sareum’s share price surged 14.9% on the operations update. The firm updated investors on its SDC-1801 and 1802 drug molecules.